A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch
- PMID: 33620312
- PMCID: PMC7997657
- DOI: 10.7554/eLife.61268
A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch
Abstract
Optogenetics enables genome manipulations with high spatiotemporal resolution, opening exciting possibilities for fundamental and applied biological research. Here, we report the development of LiCre, a novel light-inducible Cre recombinase. LiCre is made of a single flavin-containing protein comprising the AsLOV2 photoreceptor domain of Avena sativa fused to a Cre variant carrying destabilizing mutations in its N-terminal and C-terminal domains. LiCre can be activated within minutes of illumination with blue light without the need of additional chemicals. When compared to existing photoactivatable Cre recombinases based on two split units, LiCre displayed faster and stronger activation by light as well as a lower residual activity in the dark. LiCre was efficient both in yeast, where it allowed us to control the production of β-carotene with light, and human cells. Given its simplicity and performances, LiCre is particularly suited for fundamental and biomedical research, as well as for controlling industrial bioprocesses.
Keywords: Cre/Lox; DNA recombination; S. cerevisiae; biochemistry; chemical biology; genetics; genome editing; genomics; human; optogenetics; synthetic biology.
Plain language summary
In a biologist’s toolkit, the Cre protein holds a special place. Naturally found in certain viruses, this enzyme recognises and modifies specific genetic sequences, creating changes that switch on or off whatever gene is close by. Genetically engineering cells or organisms so that they carry Cre and its target sequences allows scientists to control the activation of a given gene, often in a single tissue or organ. However, this relies on the ability to activate the Cre protein ‘on demand’ once it is in the cells of interest. One way to do so is to split the enzyme into two pieces, which can then reassemble when exposed to blue light. Yet, this involves the challenging step of introducing both parts separately into a tissue. Instead, Duplus-Bottin et al. engineered LiCre, a new system where a large section of the Cre protein is fused to a light sensor used by oats to detect their environment. LiCre is off in the dark, but it starts to recognize and modify Cre target sequences when exposed to blue light. Duplus-Bottin et al. then assessed how LiCre compares to the two-part Cre system in baker's yeast and human kidney cells. This showed that the new protein is less ‘incorrectly’ active in the dark, and can switch on faster under blue light. The improved approach could give scientists a better tool to study the role of certain genes at precise locations and time points, but also help them to harness genetic sequences for industry or during gene therapy.
© 2021, Duplus-Bottin et al.
Conflict of interest statement
HD, MS, GY A patent application covering LiCre and its potential applications has been filed. Ref: FR3079832 A1 and WO2019193205. Patent applicant: CNRS; inventors: Hélène Duplus-Bottin, Martin Spichty and Gaël Yvert. GT, CP, PM, TO, FV No competing interests declared
Figures











Similar articles
-
Precise optical control of gene expression in C elegans using improved genetic code expansion and Cre recombinase.Elife. 2021 Aug 5;10:e67075. doi: 10.7554/eLife.67075. Elife. 2021. PMID: 34350826 Free PMC article.
-
Light-Inducible Recombinases for Bacterial Optogenetics.ACS Synth Biol. 2020 Feb 21;9(2):227-235. doi: 10.1021/acssynbio.9b00395. Epub 2020 Jan 21. ACS Synth Biol. 2020. PMID: 31961670 Free PMC article.
-
A photoactivatable Cre-loxP recombination system for optogenetic genome engineering.Nat Chem Biol. 2016 Dec;12(12):1059-1064. doi: 10.1038/nchembio.2205. Epub 2016 Oct 10. Nat Chem Biol. 2016. PMID: 27723747
-
Optically Controlled CRISPR-Cas9 and Cre Recombinase for Spatiotemporal Gene Editing: A Review.ACS Synth Biol. 2024 Jan 19;13(1):25-44. doi: 10.1021/acssynbio.3c00596. Epub 2023 Dec 22. ACS Synth Biol. 2024. PMID: 38134336 Review.
-
[Manipulating Living Systems by Light].Yakugaku Zasshi. 2020;140(8):993-1000. doi: 10.1248/yakushi.20-00012-5. Yakugaku Zasshi. 2020. PMID: 32741873 Review. Japanese.
Cited by
-
Optophysiology: Illuminating cell physiology with optogenetics.Physiol Rev. 2022 Jul 1;102(3):1263-1325. doi: 10.1152/physrev.00021.2021. Epub 2022 Jan 24. Physiol Rev. 2022. PMID: 35072525 Free PMC article. Review.
-
Optogenetics for transcriptional programming and genetic engineering.Trends Genet. 2022 Dec;38(12):1253-1270. doi: 10.1016/j.tig.2022.05.014. Epub 2022 Jun 20. Trends Genet. 2022. PMID: 35738948 Free PMC article. Review.
-
A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice.Nucleic Acids Res. 2025 Aug 11;53(15):gkaf758. doi: 10.1093/nar/gkaf758. Nucleic Acids Res. 2025. PMID: 40795961 Free PMC article.
-
An expanding molecular toolbox untangles neural circuits.Nature. 2021 Nov;599(7884):335-337. doi: 10.1038/d41586-021-03054-9. Nature. 2021. PMID: 34754087 No abstract available.
-
OptoLacI: optogenetically engineered lactose operon repressor LacI responsive to light instead of IPTG.Nucleic Acids Res. 2024 Jul 22;52(13):8003-8016. doi: 10.1093/nar/gkae479. Nucleic Acids Res. 2024. PMID: 38860425 Free PMC article.
References
-
- Allen ME, Zhou W, Thangaraj J, Kyriakakis P, Wu Y, Huang Z, Ho P, Pan Y, Limsakul P, Xu X, Wang Y. An AND-Gated drug and photoactivatable Cre-loxP System for Spatiotemporal Control in Cell-Based Therapeutics. ACS Synthetic Biology. 2019;8:2359–2371. doi: 10.1021/acssynbio.9b00175. - DOI - PMC - PubMed
-
- Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. CHARMM: the biomolecular simulation program. Journal of Computational Chemistry. 2009;30:1545–1614. doi: 10.1002/jcc.21287. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials